Sanofi and GSK announced on 14 April 2020 that they will work together on the development of a new, adjuvanted vaccine for COVID-19. The collaboration for the first time brings together the scientific and manufacturing expertise and resources of two global scale vaccines specialists to address the urgent global need for a vaccine to protect people from this disease.
Source: GSK